Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.19B |
| 2 |
GE Vernova
GEV
|
+$1.16B |
| 3 |
Meta Platforms (Facebook)
META
|
+$501M |
| 4 |
Palantir
PLTR
|
+$451M |
| 5 |
DoorDash
DASH
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.22B |
| 2 |
Ascendis Pharma A/S
ASND
|
+$866M |
| 3 |
Applovin
APP
|
+$690M |
| 4 |
DAY
Dayforce
DAY
|
+$576M |
| 5 |
Workday
WDAY
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.5% |
| 2 | Healthcare | 20.49% |
| 3 | Industrials | 11.17% |
| 4 | Consumer Discretionary | 9.27% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Lexeo Therapeutics
LXEO
$366M
| $28.5M | 0.01% |
4,976,429
-533,206
| -10% | -$3.78M |
|
527
Centene
CNC
$31.3B
| $28.3M | 0.01% |
865,760
+31,485
| +4% | +$1.29M |
|
528
Chesapeake Utilities
CPK
$3.26B
| $28.1M | 0.01% |
222,762
| – | – |
|
529
Parker-Hannifin
PH
$125B
| $28.1M | 0.01% |
31,409
+686
| +2% | +$649K |
|
530
Vale
VALE
$62.9B
| $28.1M | 0.01% |
1,763,906
+648,407
| +58% | +$10.1M |
|
531
Linde
LIN
$237B
| $28.1M | 0.01% |
56,668
-199,692
| -78% | -$94.2M |
|
532
Cal-Maine
CALM
$4.28B
| $28M | 0.01% |
353,751
+144,140
| +69% | +$11.8M |
|
533
ODDITY Tech
ODD
$708M
| $27.9M | 0.01% |
2,086,916
-337,001
| -14% | -$8.44M |
|
534
CAMP4 Therapeutics
CAMP
$164M
| $27.9M | 0.01% |
6,307,636
| – | – |
|
535
MarketAxess Holdings
MKTX
$4.15B
| $27.8M | 0.01% |
168,797
+350
| +0.2% | +$61.3K |
|
536
Alamo Group
ALG
$2.01B
| $27.7M | 0.01% |
167,983
+20,410
| +14% | +$3.85M |
|
537
Fulton Financial
FULT
$4.7B
| $27.7M | 0.01% |
1,360,809
-415,801
| -23% | -$8.57M |
|
538
Cheniere Energy
LNG
$56.5B
| $27.6M | 0.01% |
97,361
-22,264
| -19% | -$5.14M |
|
539
Ryman Hospitality Properties
RHP
$8.4B
| $27.4M | 0.01% |
297,426
+14,152
| +5% | +$1.36M |
|
|
MRSH
540
Marsh
MRSH
$86.3B
| $27.3M | 0.01% |
157,363
-225,633
| -59% | -$40.6M |
|
541
Protara Therapeutics
TARA
$226M
| $27.2M | 0.01% |
5,207,011
+65,395
| +1% | +$387K |
|
542
Box
BOX
$4.02B
| $27.1M | 0.01% |
1,147,381
+491,505
| +75% | +$12.4M |
|
543
Landstar System
LSTR
$6.8B
| $26.8M | 0.01% |
166,984
+67
| +0% | +$10.3K |
|
544
Business First Bancshares
BFST
$1.02B
| $26.8M | 0.01% |
989,686
+3,540
| +0.4% | +$97.2K |
|
545
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.56B
| $26.5M | 0.01% |
445,283
-24,197
| -5% | -$1.46M |
|
|
GRFS
546
Grifois
GRFS
$5.16B
| $26.4M | 0.01% |
3,290,089
-129,687
| -4% | -$1.14M |
|
547
Dream Finders Homes
DFH
$1.46B
| $26.1M | 0.01% |
1,876,795
+92,691
| +5% | +$1.65M |
|
|
AKTS
548
Aktis Oncology
AKTS
$1.32B
| $26M | 0.01% |
+1,454,267
| New | +$28.2M |
|
549
Hudbay
HBM
$9.92B
| $26M | 0.01% |
+1,243,668
| New | +$29.1M |
|
550
Black Hills Corp
BKH
$5.73B
| $25.9M | 0.01% |
373,694
-24,726
| -6% | -$1.78M |
|
Similar funds
Janus Henderson Group's Q1 2026 Portfolio in Review
As of Q1 2026, Janus Henderson Group held 2,488 positions worth $209B, down 6.2% from $223B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Janus Henderson Group's Q1 2026 filing shows 82 new, 739 increased, 627 reduced and 81 closed positions. Its largest new stake was Forgent Power Solutions: 7,769,612 shares worth $227M. The largest sale was Microsoft, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2026 buy was Forgent Power Solutions: 7,769,612 shares worth $227M.
- Janus Henderson Group added most to AstraZeneca in Q1 2026, an estimated $2.19B increase.
- Janus Henderson Group's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Ascendis Pharma A/S in Q1 2026, selling an estimated $866M.
- Janus Henderson Group's ten largest holdings make up 30% of its $209B portfolio in Q1 2026.
- Janus Henderson Group opened 82 new positions and closed 81 in Q1 2026.
- Janus Henderson Group's portfolio value fell 6.2% quarter-over-quarter to $209B.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.